Hospices Civils de Lyon: Shock, Septic trials

The registry lists 14 Shock, Septic studies with Hospices Civils de Lyon as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 2 1Phase 3 2Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic ShockNot yet recruitingNCT07569536Phase 3
• Remote Ischemic Postconditioning in Septic ShockNot yet recruitingNCT07273942Not applicable
• Prodromes of Menstrual Staphylococcal Toxic ShockRecruitingNCT06124599
• Septic Shock-induced ImmunosuppressionRecruitingNCT04067674
• Cirrhotic Patients With Septic ShockCompletedNCT03987048
• REmote Ischemic COnditioning in Septic ShockCompletedNCT03201575Not applicable
• Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in ChildrenWithdrawnNCT02899702Phase 4
• Pediatric Immune Response to Infectious ShockCompletedNCT02848144Not applicable
• Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)Status unknownNCT02803346
• REAnimation Low Immune Status MarkersCompletedNCT02638779Not applicable
• GM-CSF to Decrease ICU Acquired InfectionsCompletedNCT02361528Phase 3
• Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot StudyCompletedNCT02219165Phase 2
• Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1CompletedNCT01972828Not applicable
• Citrate Versus Heparin Anticoagulation: Effect on Molecules ClearancesStatus unknownNCT01839578Not applicable